Israeli Scientists Uncover Therapy That Converts Cancer Cells Into Normal Ones

Cancer cells, by definition, are abnormal cells that divide with abandon and have the potential to spread throughout and wreak havoc on your vital organs and tissues. But what if you could tell those same troublesome cells to stop misbehaving? Israeli scientists think they’ve found a way to do just that.

A group of researchers at Ben-Gurion University of the Negev, led by Professor Varda Shoshan-Barmatz, PhD, have developed a molecule that prevents cancer cells from growing and turns them into normal, non-cancerous cells. This unique approach is based on siRNA (small interfering ribonucleic acid), a molecule that turns off a protein, VDAC1, that helps get energy to malignant cells. By targeting VDAC1, Shoshan-Barmatz and her team have essentially figured out how to make cancer cells start acting like regular ones.

So far, in vitro and mice models have suggested that this treatment might be effective for lung cancer, triple negative breast cancer, and glioblastoma (the type of brain tumor that John McCain is currently battling). But the applications might be even broader, and similar treatments might be one day used to combat an even wider variety of cancers.

“Although this is in the early stages, we are excited with results that demonstrate this novel molecule’s potential for cancer treatment,” Shoshan-Barmatz said in a press release. “Using the siRNA treatment for several types of cancer in mouse models reprogrammed cancer cell metabolism, reduced tumor growth and angiogenesis, reduced tumor invasiveness, and induced cancer stem cell disappearance and cell differentiation.”

Also worth noting: The siRNA treatment did not impact non-cancerous cells, which indicates that it has the potential to be a well-controlled, safe approach.

BGN Technologies, the technology-transfer company of Ben-Gurion University of the Negev, has already patented the technology discovered by Shoshan-Barmatz and her colleagues. Next up, BGN will be identifying partners to develop and advance research on this molecule. A series of clinical trials are expected to follow.

This particular cancer-fighting strategy is just one of many that Shoshan-Barmatz is currently exploring in her lab. The former director of The National Institute for Biotechnology in the Negev, she’s also focusing on the VDAC1 protein as a means to induce death in cancer cells.

Barbara Brody is a freelance writer/editor specializing in health and wellness. Head to her website or follow her on Twitter.

Author

Your Comments

The Forward welcomes reader comments in order to promote thoughtful discussion on issues of importance to the Jewish community. All readers can browse the comments, and all Forward subscribers can add to the conversation. In the interest of maintaining a civil forum, The Forward requires that all commenters be appropriately respectful toward our writers, other commenters and the subjects of the articles. Vigorous debate and reasoned critique are welcome; name-calling and personal invective are not and will be deleted. Egregious commenters or repeat offenders will be banned from commenting. While we generally do not seek to edit or actively moderate comments, our spam filter prevents most links and certain key words from being posted and the Forward reserves the right to remove comments for any reason.

Recommend this article

Israeli Scientists Uncover Therapy That Converts Cancer Cells Into Normal Ones

Thank you!

This article has been sent!

Close